Sanofi has committed an additional $625m to its venture capital arm, Sanofi Ventures, bringing its total assets under management to more than$1.4bn. The move aims to bolster investments in biotech and digital health innovations, aligning with Sanofi's strategic focus on immunology, neurology, vaccines and rare diseases. Established in 2012, Sanofi Ventures has invested $800m in more than 70 companies, targeting early-stage and emerging opportunities in healthcare. The fund participates in various stage ...